Osaic Holdings’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1
Closed -$2K 6799
2020
Q4
$2K Buy
+1
New +$258 ﹤0.01% 6039
2020
Q2
Sell
-1
Closed -$2K 6110
2020
Q1
$2K Buy
+1
New +$303 ﹤0.01% 5648

Other funds holding BIIB

Osaic Holdings's BIIB Position: Q1 2026 in Review

Osaic Holdings reduced its Biogen (BIIB) stake by 17% in Q1 2026, selling an estimated $450K and leaving 12,005 shares worth $2.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1994.

Osaic Holdings first reported a position in BIIB in Q1 2020 and has held it in 25 quarters since. The position peaked at $12.6M in Q2 2021. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Osaic Holdings held 12,005 shares of Biogen worth $2.2M as of Q1 2026.
  • Osaic Holdings sold 2,442 Biogen shares in Q1 2026, an estimated $450K.
  • Biogen made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #1994 holding.
  • Osaic Holdings first reported a position in Biogen in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Biogen position peaked at $12.6M in Q2 2021.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.